首页> 美国卫生研究院文献>ACS Omega >NMR Assays for Estimating the O-AcetylContent of Meningococcal Polysaccharide Serogroup A in QuadrivalentConjugate Vaccine Formulation
【2h】

NMR Assays for Estimating the O-AcetylContent of Meningococcal Polysaccharide Serogroup A in QuadrivalentConjugate Vaccine Formulation

机译:估计邻乙酰的NMR分析脑膜炎球菌多糖血清群A的四价含量共轭疫苗配方

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The use of multivalent glycoconjugate vaccines has dramatically contributed to reduce the incidence of meningococcal infectious disease. The advanced structural characterization of polysaccharide conjugates leads to enhancements in the quality and control of the products. Here, we report a novel nuclear magnetic resonance (NMR) method to confirm the identity and structural conformity (e.g., O-acetyl content) of saccharide antigens that comprise a licensed tetravalent meningococcal serogroups A, C, W, and Y vaccine. For the first time, the NMR methodology is applied on a formulation (licensed vaccine) containing a large excess of excipient (i.e., sucrose) without analytical sample pretreatment. This work confirms the applicability of a rapid and easy NMR assay on a multivalent conjugate vaccine, which might be extended to other combination vaccines that are already licensed or in clinical development.
机译:多价糖缀合物疫苗的使用极大地减少了脑膜炎球菌感染性疾病的发生。多糖缀合物的先进结构表征导致产品质量和控制的提高。在这里,我们报告了一种新颖的核磁共振(NMR)方法,以确认糖类抗原的身份和结构一致性(例如O-乙酰基含量),所述糖类抗原包含许可的四价脑膜炎球菌血清群A,C,W和Y疫苗。首次将NMR方法应用于含有大量过量的赋形剂(即蔗糖)的制剂(许可疫苗),而无需进行分析样品预处理。这项工作证实了快速,简便的NMR分析在多价结合疫苗上的适用性,该方法可能会扩展到已获许可或正在临床开发中的其他组合疫苗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号